1-[1H-imidazol-4(5)-yl]propan-1-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-[1H-imidazol-4(5)-yl]propan-1-one
• 英文别名: 1-(1H-imidazol-4-yl)-1-propanone；(1H-imidazol-4-yl)-1-propanone；1-(1H-imidazol-4-yl)propan-1-one；1-(1H-imidazol-5-yl)propan-1-one
• 化学式: C₆H₈N₂O
• mdl: MFCD19216577
• 分子量: 124.142
• InChiKey: KLQYXTXNODUHGR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  45.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[1H-imidazol-4(5)-yl]propan-1-one 在 盐酸羟胺 、 氢气 、 potassium carbonate 、 三乙胺 作用下， 以 甲醇 、 乙醇 、 1,2-二氯乙烷 为溶剂， 10.0~50.0 ℃ 、344.75 kPa 条件下， 反应 8.0h， 生成 1-[1-(2,2,2-Trifluoroethyl)imidazol-4-yl]propan-1-amine
  参考文献：
  名称：

  NITROGENATED HETEROCYCLIC COMPOUND

  摘要：

  公开号：

  EP2848618B1
• 作为产物：
  描述：

  1-(1-trityl-1H-imidazol-4-yl)propan-1-ol 在 盐酸 、 manganese(IV) oxide 作用下， 以 1,4-二氧六环 、 乙酸乙酯 为溶剂， 反应 4.0h， 生成 1-[1H-imidazol-4(5)-yl]propan-1-one
  参考文献：
  名称：

  NITROGENATED HETEROCYCLIC COMPOUND

  摘要：

  公开号：

  EP2848618B1

文献信息

• PROCESS FOR THE PREPARATION OF IMIDAZOLE DERIVATIVES
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1193258A1

  公开（公告）日：2002-04-03

  The present invention provides an industrially advantageous production method of compound (V) having a steroid C17,20 lyase inhibitory action, which affords this compound in a high yield with a less number of steps without using a heavy metal compound: wherein ring A is an optionally substituted imidazole ring, R is an optionally substituted hydrocarbon group or a heterocyclic group, and R1, R2, R3, R4, R5, R6 and R7 are each a hydrogen atom, an optionally substituted hydrocarbon group, OH, SH or NH2, an acyl group or a halogen and the like.

  本发明提供了一种在不使用重金属化合物的情况下，以较少的步骤高产率地制备具有类固醇C17,20裂解酶抑制作用的化合物（V）的工业上有利的生产方法：其中环A是一个可选择取代的咪唑环，R是一个可选择取代的碳氢化合物基团或杂环基团，R1、R2、R3、R4、R5、R6和R7分别是氢原子、可选择取代的碳氢化合物基团、羟基、硫氢基或氨基、酰基或卤素等。
• A Convenient Synthesis of 4(5)-Alkylacyl-1<i>H</i>-imidazoles from 4(5)-Imidazolecarboxaldehyde
  作者：Jun-ichi Kawakami、Kazuhiro Kimura、Masayoshi Yamaoka

  DOI：10.1055/s-2003-38067

  日期：——

  A convenient synthesis of 4(5)-acyl-1H-imidazoles from 4(5)-imidazolecarboxaldehyde without N-protecting group is described. 4(5)-Cyanoimidazole could be synthesized from commercially available 4(5)-imidazolecarboxaldehyde in one-pot. Treatment of 4(5)-cyanoimidazole with various alkylmagnesium bromides followed by addition of aqueous sulfuric acid afforded 4(5)-acyl-1H-imidazoles in good yield.

  描述了一种方便的合成 4(5)-acyl-1H-imidazoles 从 4(5)-imidazolecarboxaldehyde 没有 N-保护基团。4(5)-氰基咪唑可以从市售的4(5)-咪唑甲醛一锅法合成。用各种烷基溴化镁处理 4(5)-氰基咪唑，然后加入硫酸水溶液，以良好的收率得到 4(5)-酰基-1H-咪唑。
• Hepatitis C Virus Inhibitors
  申请人：Bachand Carol

  公开号：US20080050336A1

  公开（公告）日：2008-02-28

  The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

  本公开涉及化合物、组合物和治疗丙型肝炎病毒（HCV）感染的方法。还公开了含有这些化合物的药物组合物以及使用这些化合物治疗HCV感染的方法。
• 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US06518257B1

  公开（公告）日：2003-02-11

  To provide a composition having a steroid C17,20-lyase inhibitory activity and useful as an agent for the prophylaxis or treatment of prostatism and tumors such as breast cancer. A compound represented by the formula: wherein R is a hydrogen atom or a protecting group, R1 is a lower alkyl group or a cyclic hydrocarbon group, R2 is an aromatic hydrocarbon group optionally having substituents or an aromatic heterocyclic group optionally having substituents, R3 is a hydrocarbon group optionally having substituents, a hydroxyl group optionally having substituents, a thiol group optionally having substituents, an amino group optionally having substituents, an acyl group or a halogen atom, and n is an integer of 0 to 4, and a salt thereof have a steroid C17,20-lyase inhibitory activity, and are useful as an agent for the pophylaxis or treatment of prostatism and tumors such as beast cancer and the like.

  提供一种具有类固醇C17,20-裂解酶抑制活性的化合物，并且作为预防或治疗前列腺增生和乳腺癌等肿瘤的药物。所述化合物的结构式如下：其中R为氢原子或保护基，R1为较低的烷基或环烃基，R2为芳香烃基，可选择地具有取代基，或芳香杂环基，可选择地具有取代基，R3为烃基，可选择地具有取代基，羟基，可选择地具有取代基，硫醇基，可选择地具有取代基，氨基，可选择地具有取代基，酰基或卤原子，n为0到4的整数，以及其盐具有类固醇C17,20-裂解酶抑制活性，并且作为预防或治疗前列腺增生和乳腺癌等肿瘤的药物。
• Amide of r-2-(aminoaryl)-propionic acid for use in theprevention of leucocyte activation
  申请人：——

  公开号：US20040186146A1

  公开（公告）日：2004-09-23

  N-(2-aminoaryl-propionyl)-amides of formula (1) are described. 1 The process for their preparation and pharmaceutical preparations thereof are also described. The amides of the invention are useful in the prevention and treatment of tissue damage due to the exacerbate recruitment of polymorphonuclear neutrophils (leukocytes PMN) at the inflammatory sites. In particular, the invention relates to the R enantiomers of 2-(aminoaryl)-propionyl amides of formula (1) for use in the ihibition of the chemotaxis of neutrophils induced by IL-8. The compounds of the invention are used in the treatment of psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis.

  描述了式（1）的N-(2-氨基芳基丙酰基)-酰胺。还描述了它们的制备过程和制药制剂。本发明的酰胺在预防和治疗由于炎症部位过度招募多形核中性粒细胞（白细胞PMN）引起的组织损伤方面是有用的。特别地，本发明涉及式（1）的2-(氨基芳基)-丙酰基酰胺的R对映体，用于抑制IL-8诱导的中性粒细胞趋化。本发明的化合物用于治疗牛皮癣、溃疡性结肠炎、肾小球肾炎、急性呼吸功能不全、特发性纤维化和类风湿性关节炎。